SITC Announces EU Immuno-oncology Drug Development Summit - Bringing the European IO Community Together to Foster the Next Wave of IO Therapeutics

posted 14 hours ago
Keynote Address featuring Dr. E. John Wherry – “Intersection of IO and Autoimmunity” MILWAUKEE, WI – The Society for Immunotherapy of Cancer (SITC) is proud to announce the upcoming EU Immuno-oncology Drug Development ...
0 comments

SITC and CRI Launch Annual Collaboration Bringing the Prestigious CRI William B. Coley Award Lecture to the SITC Annual Meeting

posted yesterday
NK cell pioneer Éric Vivier, DVM, PhD, to deliver the inaugural lecture at SITC 2026 MILWAUKEE, WI – The Society for Immunotherapy of Cancer (SITC) and t he Cancer Research Institute (CRI) are proud to announce the ...
0 comments

JITC Digest July 2026

posted 7 days ago
INSIDE THIS ISSUE: Letter from the Editor| JITC Editor Picks|New Special Series Myeloid Cells in Immuno-Oncology| JITC Meet-the-Editor Seession at JACI (Japan)| Popular Articles Letter from the Editor ...
0 comments

Oncology News Burst from the FDA: FDA Approves Pembrolizumab or Pembrolizumab and Berahyaluronidase Alfa-pmph Each with Enfortumab Vedotin-ejfv for Muscle Invasive Bladder Cancer

posted 9 days ago
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will periodically distribute information about newly approved therapies for cancer patients. This helps the FDA inform oncologists ...
0 comments

SITC Raises Concerns About Proposed Changes to Federal Grant-Making Rules

posted 15 days ago
The Society for Immunotherapy of Cancer (SITC) has submitted comments to the Office of Management and Budget (OMB) regarding proposed changes to the regulations governing Federal Financial Assistance . View the comments ...
0 comments

Oncology News Burst from the FDA: FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor Hematopoietic Stem Cell Transplantation for Adults with Hematologic Malignancies

posted 21 days ago
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will periodically distribute information about newly approved therapies for cancer patients. This helps the FDA inform oncologists ...
0 comments

Immune Monitor - June 2026

posted 21 days ago
A Message from the President As Cancer Immunotherapy Awareness Month comes to a close, I’m reflecting on the remarkable progress and momentum in the field of cancer immuno-oncology. Throughout June, our community celebrated ...
0 comments

Oncology News Burst from the FDA: FDA Approves Sacituzumab Govitecan-hziy as Monotherapy and in Combination with Pembrolizumab for First-Line Treatment of Triple-Negative Breast Cancer

posted 22 days ago
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will periodically distribute information about newly approved therapies for cancer patients. This helps the FDA inform oncologists ...
0 comments

Oncology News Burst from the FDA: FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of renal cell carcinoma

posted 23 days ago
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will periodically distribute information about newly approved therapies for cancer patients. This helps the FDA inform oncologists ...
0 comments

JITC Digest June 2026

posted 06-17-2026
INSIDE THIS ISSUE: Letter from the Editor| JITC Editor Picks|SITC 40 th Anniversary Special Series| Popular Articles Letter from the Editor Hello JITC Readers, June is ...
0 comments

2026 ASCO Annual Meeting Scientific Highlights - June 2

posted 06-03-2026
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, June 2, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific ...
0 comments

2026 ASCO Annual Meeting Scientific Highlights - June 1

posted 06-02-2026
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, June 1, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific ...
0 comments

2026 ASCO Annual Meeting Scientific Highlights - May 31

posted 06-01-2026
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, May 31, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific ...
0 comments

Immune Monitor - May 2026

posted 06-01-2026
A Message from the President The pace of discovery in cancer immunotherapy continues to accelerate, creating both extraordinary opportunity and an urgent need for collaboration. For more than 40 years, the Society ...
0 comments

2026 ASCO Annual Meeting Scientific Highlights - May 30

posted 05-31-2026
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, May 30, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific ...
0 comments

2026 ASCO Annual Meeting Scientific Highlights - May 29

posted 05-30-2026
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, May 29, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific ...
0 comments

SITC Signs onto ACS CAN Letter Urging Protection of the USPSTF

posted 05-28-2026
The Society for Immunotherapy of Cancer (SITC) joined more than 60 cancer patient and provider organizations in signing onto a coalition letter led by the American Cancer Society Cancer Action Network (ACS CAN) directed ...
0 comments

NEW! The Role of Local Immunotherapy in the Treatment of Cancer

posted 05-27-2026
Edited by Tanja D. de Gruijl, PhD and Howard Kaufman, MD, FACS While local immunotherapy has the potential to deliver high doses of immune potentiating agents with limited systemic toxicity, clinical development and ...
0 comments

SITC Signs onto OVAC Letter Supporting Timely Cancer Research Funding

posted 05-22-2026
The Society for Immunotherapy of Cancer (SITC) joined more than 50 organizations through One Voice Against Cancer (OVAC) in signing a coalition letter to Congress raising concerns about delays and disruptions in federal cancer ...
0 comments

SITC 2026 Keynote and Registration Press Release

posted 05-20-2026
SITC Announces Keynote Speakers Dr. Ton Schumacher and Dr. Catherine J. Wu at its 41 st Annual Meeting The largest cancer immunotherapy conference featuring the latest research in immuno-oncology MILWAUKEE, ...
0 comments

Back to SITC Cancer Immunotherapy Guidelines